Emerging role of exosomes in cancer progression and tumor microenvironment remodeling MDA Paskeh, M Entezari, S Mirzaei, A Zabolian, H Saleki, MJ Naghdi, ... Journal of hematology & oncology 15 (1), 83, 2022 | 373 | 2022 |
Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention S Mirzaei, MDA Paskeh, E Okina, MH Gholami, K Hushmandi, M Hashemi, ... Journal of Experimental & Clinical Cancer Research 41 (1), 214, 2022 | 126 | 2022 |
Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response M Ashrafizadeh, MDA Paskeh, S Mirzaei, MH Gholami, A Zarrabi, ... Journal of Experimental & Clinical Cancer Research 41 (1), 105, 2022 | 118 | 2022 |
Wnt/β-Catenin Signaling as a Driver of Hepatocellular Carcinoma Progression: An Emphasis on Molecular Pathways SG Deldar Abad Paskeh M, Mirzaei S, Ashrafizadeh M, Zarrabi A Journal of Hepatocellular Carcinoma 2021 (8), 1415—1444, 2021 | 91 | 2021 |
Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges MDA Paskeh, F Ghadyani, M Hashemi, A Abbaspour, A Zabolian, ... Pharmacological research 187, 106553, 2023 | 81 | 2023 |
Graphene oxide nanoarchitectures in cancer biology: Nano-modulators of autophagy and apoptosis A Taheriazam, GGY Abad, S Hajimazdarany, MH Imani, S Ziaolhagh, ... Journal of Controlled Release 354, 503-522, 2023 | 60 | 2023 |
Targeted regulation of autophagy using nanoparticles: New insight into cancer therapy MDA Paskeh, M Entezari, C Clark, A Zabolian, E Ranjbar, MV Farahani, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1868 (3), 166326, 2022 | 55 | 2022 |
Revealing the role of miRNA-489 as a new onco-suppressor factor in different cancers based on pre-clinical and clinical evidence MDA Paskeh, S Mirzaei, S Orouei, A Zabolian, H Saleki, N Azami, ... International Journal of Biological Macromolecules 191, 727-737, 2021 | 47 | 2021 |
Transforming growth factor-beta (TGF-β) in prostate cancer: A dual function mediator? S Mirzaei, MDA Paskeh, Y Saghari, A Zarrabi, MR Hamblin, M Entezari, ... International Journal of Biological Macromolecules 206, 435-452, 2022 | 44 | 2022 |
EZH2 as a new therapeutic target in brain tumors: molecular landscape, therapeutic targeting and future prospects MDA Paskeh, A Mehrabi, MH Gholami, A Zabolian, E Ranjbar, H Saleki, ... Biomedicine & Pharmacotherapy 146, 112532, 2022 | 44 | 2022 |
Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies S Mirzaei, MDA Paskeh, F Hashemi, A Zabolian, M Hashemi, M Entezari, ... Life Sciences 288, 119948, 2022 | 44 | 2022 |
SOX2 function in cancers: Association with growth, invasion, stemness and therapy response S Mirzaei, MDA Paskeh, M Entezari, S reza Mirmazloomi, A Hassanpoor, ... Biomedicine & Pharmacotherapy 156, 113860, 2022 | 40 | 2022 |
Cervical cancer progression is regulated by SOX transcription factors: Revealing signaling networks and therapeutic strategies MDA Paskeh, S Mirzaei, MH Gholami, A Zarrabi, A Zabolian, M Hashemi, ... Biomedicine & Pharmacotherapy 144, 112335, 2021 | 36 | 2021 |
Targeting cancer stem cells by dietary agents: an important therapeutic strategy against human malignancies M Deldar Abad Paskeh, S Asadi, A Zabolian, H Saleki, MA Khoshbakht, ... International Journal of Molecular Sciences 22 (21), 11669, 2021 | 34 | 2021 |
Targeting AMPK signaling in ischemic/reperfusion injury: From molecular mechanism to pharmacological interventions MDA Paskeh, A Asadi, S Mirzaei, M Hashemi, M Entezari, R Raesi, ... Cellular Signalling 94, 110323, 2022 | 31 | 2022 |
Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapy MDA Paskeh, H Saebfar, MK Mahabady, S Orouei, K Hushmandi, ... Life Sciences 298, 120463, 2022 | 30 | 2022 |
STAT3 signaling in prostate cancer progression and therapy resistance: An oncogenic pathway with diverse functions M Sadrkhanloo, MDA Paskeh, M Hashemi, R Raesi, M Motahhary, ... Biomedicine & Pharmacotherapy 158, 114168, 2023 | 24 | 2023 |
Drug repositioning in non‑small cell lung cancer (NSCLC) using gene co‑expression and drug–gene interaction networks analysis AMN Habib MotieGhader, Parinaz Tabrizi-Nezhadi, Mahshid Deldar Abad Paskeh ... Scientific Reports, 2022 | 21 | 2022 |
Towards dual function of autophagy in breast cancer: A potent regulator of tumor progression and therapy response M Hashemi, MDA Paskeh, S Orouei, P Abbasi, R Khorrami, ... Biomedicine & Pharmacotherapy 161, 114546, 2023 | 17 | 2023 |
Epigenetic regulation of autophagy by non-coding RNAs in gastrointestinal tumors: Biological functions and therapeutic perspectives MA Zandieh, MH Farahani, R Rajabi, ST Avval, K Karimi, P Rahmanian, ... Pharmacological Research 187, 106582, 2023 | 17 | 2023 |